Table 1.
Variable | Control group (n = 17) | Wilcoxon U test p-value |
RR-MS group (n = 22) | Wilcoxon U test p-value |
||
---|---|---|---|---|---|---|
|
|
|||||
Serum | CSF | Serum | CSF | |||
IL-17 (pg/mL) | 8.3 ± 2.7 | 25.7 ± 2.9 | 0.144 | 15.7 ± 2.4* | 20.6 ± 2.9 | 0.208 |
IL-1β (pg/ mL) | 19.4 ± 4.3 | 6.2 ± 0.8 | 0.013 | 97.4 ± 26.1* | 25.0 ± 7.2* | 0.021 |
ACh (pmol/ mL) | 586.9 ± 149.4 | 393.6 ± 142.5 | 0.917 | 175.4 ± 68.9* | 124.3 ± 56.4* | 0.686 |
Wilcoxon U test p-value relative to comparison serum vs. CSF values within each group;
p < 0.05;
Mann-Whitney U test relative to comparison RR-MS group vs. Control group